Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded
| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| +0.11% | -3.67% | +15.66% | -20.62% | 62.28B | |
| -3.82% | +1.30% | +63.26% | +211.79% | 60.59B | |
| +0.70% | +29.50% | +29.50% | +29.50% | 39.55B | |
| -1.84% | +6.09% | -55.86% | -62.24% | 36.8B | |
| +0.05% | +2.41% | +53.12% | -33.31% | 29.53B | |
| +0.65% | +6.01% | +60.19% | +76.64% | 21.68B | |
| +0.54% | +5.21% | +87.14% | -60.40% | 19.8B | |
| +1.24% | +5.67% | -3.61% | +127.98% | 16.96B | |
| -0.05% | -1.13% | +52.11% | +99.73% | 16.16B | |
| Average | -0.15% | +3.05% | +33.50% | +41.01% | 33.71B | |
| Weighted average by Cap. | -0.66% | +2.95% | +30.66% | +45.12% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.88M 2.66M 2.49M 4.66M 317M 4.73M 31.38M 12.23M 154M 12.53M 12.26M 535M | 6.18M 5.34M 4.92M 4.6M 8.63M 587M 8.76M 58.08M 22.64M 286M 23.19M 22.7M 990M |
| Net income | 1.4M 1.21M 1.12M 1.04M 1.96M 133M 1.99M 13.18M 5.14M 64.88M 5.26M 5.15M 225M | 2.41M 2.08M 1.92M 1.8M 3.36M 229M 3.42M 22.65M 8.83M 111M 9.04M 8.85M 386M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
